News > Japan recognises India's Covaxin to facilitate travel between countries

Japan recognises India's Covaxin to facilitate travel between countries

Firstpost | 07/04/2022 09:48 PM | Click to read full article

Japan recognizes India's COVID-19 vaccine Covaxin manufactured by Bharat Biotech with effect from 10 April to further facilitate travel from India to Japan, said the Indian Embassy in Japan on Thursday.

The government of Japan includes the indigenously developed and manufactured COVID-19 vaccine COVAXIN by Bharat Biotech of India, as one of the recognised vaccines for 1st and 2nd dose with effect from 10 April 2022 to further facilitate travel from India to Japan.